Predicting Drug Response in Human Prostate Cancer from Preclinical Analysis of In Vivo Mouse Models

Although genetically engineered mouse (GEM) models are often used to evaluate cancer therapies, extrapolation of such preclinical data to human cancer can be challenging. Here, we introduce an approach that uses drug perturbation data from GEM models to predict drug efficacy in human cancer. Network...

Full description

Bibliographic Details
Main Authors: Antonina Mitrofanova, Alvaro Aytes, Min Zou, Michael M. Shen, Cory Abate-Shen, Andrea Califano
Format: Article
Language:English
Published: Elsevier 2015-09-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124715009481